Welcome to the CBTE Board. CBTE is a profitable, growing biotech company specializing in bio defence and genetics. You won't find a cheaper profitable biotechnology company- with a 1.8 MM float and 3 MM shares ouitstanding, CBTE is trading at a $15 MM market cap. The following summarizes in detail why CBTE is a compelling investment opportunity:
1) With a market cap of $15 million, what's the downside? 2) cash is not an issue - just turned cash positive, now making money, and adding contracts, raised capital at higher levels; 3) After years of floundering around, suddenly they find themselves in not one but two sweet spots of american industry, and the bioterrorism testing business is about to explode - 4) This business has huge operating leverage as it turns profitable - an additional $10 million of revenue will add $1.20 per share of earnings. How hard is that going to be, with contract bids totalling in excess of $100 million? 5) This is compelling takeover asset for anyone interested in entering the bioterrorism testing game - CBTE has one of only 8 labs in the country approved by the DoD. 6) techincally, this is a fast shot to $6 - if it breaks out of that resistance, the neasurements are explosive 13 then 25. Hard to imagine that with another contract or two - and they are waiting on several, i hear, or with another anthrax letter anywhere in the world, this wont pop 6 in the next 30 days. 7) 3 quarters of new business - what will happen to earnings over the next 2 quarters - sequential momentum is about to pop. 8) Tiny 1.8 MM share float 9) $6.9 MM in new contracts so far this year and more expected. Project bioshield could provide CBTE contracts of much higher magnitude. 10) Terror and security stocks soaring today- momentum will continue due to security concerns with republican Convention. 11) over 100,000 shares short- short covering. 12) Markets have turned around as oil price has peaked and is falling. 13)At $25, this is still only a $40 million market cap company. Based on meetings with management, one poster believes with the momentum of the business, they have visibility on $20-30 million of revenue over the next 18 months. Remember, $10 million of revenue = $1.20 per share.